Variant report

Variant	nsv884068
Chromosome Location	chr6:30430875-30447987
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr6:30431411-30431412	K562	blood:	n/a	n/a
2	ATF3	chr6:30438818-30439151	K562	blood:	n/a	n/a
3	CCNT2	chr6:30433986-30434442	K562	blood:	n/a	chr6:30434014-30434023
4	CEBPB	chr6:30438765-30439122	K562	blood:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
5	CEBPB	chr6:30438794-30439097	A549	lung:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
6	CEBPB	chr6:30438780-30439151	IMR90	lung:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
7	CEBPB	chr6:30438777-30439163	Hela-S3	cervix:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
8	CEBPB	chr6:30438786-30439148	K562	blood:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
9	CEBPB	chr6:30438805-30439103	H1-hESC	embryonic stem cell:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
10	CEBPB	chr6:30431944-30432234	HepG2	liver:	n/a	n/a
11	CEBPB	chr6:30438803-30439128	HepG2	liver:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
12	CTCF	chr6:30432500-30432650	GM12875	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
13	CTCF	chr6:30432580-30432730	HRPEpiC	eye:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
14	CTCF	chr6:30431520-30431670	GM12871	blood:	n/a	chr6:30431623-30431636
15	CTCF	chr6:30431440-30431590	HAc	cerebellar:	n/a	n/a
16	CTCF	chr6:30432540-30432690	GM12873	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
17	CTCF	chr6:30432520-30432670	RPTEC	kidney:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
18	CTCF	chr6:30432580-30432730	WERI-Rb-1	eye:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
19	CTCF	chr6:30432520-30432670	GM12864	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
20	CTCF	chr6:30431560-30431710	GM12873	blood:	n/a	chr6:30431623-30431636
21	CTCF	chr6:30432460-30432610	GM12870	blood:	n/a	chr6:30432482-30432495
22	CTCF	chr6:30431640-30431790	BJ	skin:	n/a	n/a
23	CTCF	chr6:30432608-30432618	GM10248	blood:	n/a	n/a
24	CTCF	chr6:30431520-30431670	NB4	blood:	n/a	chr6:30431623-30431636
25	CTCF	chr6:30432560-30432710	GM12878	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
26	CTCF	chr6:30432540-30432690	GM12864	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
27	CTCF	chr6:30432620-30432770	A549	lung:	n/a	n/a
28	CTCF	chr6:30431580-30431730	GM12873	blood:	n/a	chr6:30431623-30431636
29	CTCF	chr6:30432480-30432630	NB4	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612 chr6:30432482-30432495
30	CTCF	chr6:30432580-30432730	GM12864	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
31	CTCF	chr6:30431520-30431670	HCPEpiC	choroid plexus:	n/a	chr6:30431623-30431636
32	CTCF	chr6:30432500-30432650	GM12865	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
33	CTCF	chr6:30432540-30432690	HepG2	liver:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
34	CTCF	chr6:30432555-30432645	Hela-S3	cervix:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
35	CTCF	chr6:30439665-30439743	Kidney_OC	kidney:	n/a	n/a
36	CTCF	chr6:30432560-30432710	GM12874	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
37	CTCF	chr6:30431520-30431670	GM12865	blood:	n/a	chr6:30431623-30431636
38	CTCF	chr6:30432540-30432690	GM12872	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
39	CTCF	chr6:30431540-30431690	HUVEC	blood vessel:	n/a	chr6:30431623-30431636
40	CTCF	chr6:30432880-30433030	WERI-Rb-1	eye:	n/a	n/a
41	CTCF	chr6:30432480-30432630	GM12869	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612 chr6:30432482-30432495
42	CTCF	chr6:30432580-30432730	HMEC	breast:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
43	CTCF	chr6:30432500-30432650	GM12868	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
44	CTCF	chr6:30432571-30432631	HepG2	liver:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
45	CTCF	chr6:30432980-30433130	HepG2	liver:	n/a	chr6:30433116-30433124
46	CTCF	chr6:30432480-30432630	HEK293	kidney:	n/a	chr6:30432600-30432618 chr6:30432603-30432612 chr6:30432482-30432495
47	CTCF	chr6:30431549-30431702	Spleen_OC	spleen:	n/a	chr6:30431623-30431636
48	CTCF	chr6:30432540-30432690	GM12871	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
49	CTCF	chr6:30432580-30432730	GM12878	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612
50	CTCF	chr6:30432540-30432690	GM12866	blood:	n/a	chr6:30432600-30432618 chr6:30432603-30432612

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:30434072-30434122	Caco-2	colon:	n/a
2	chr6:30431577-30431627	BE2_C	brain:	n/a
3	chr6:30434552-30434602	HRE	kidney:	n/a
4	chr6:30434291-30434341	AG04449	skin:	fetal
5	chr6:30434208-30434258	BJ	skin:	n/a
6	chr6:30430828-30430878	HCM	heart:	n/a
7	chr6:30431782-30431832	GM06990	blood:	n/a
8	chr6:30434072-30434122	Caco-2	colon:	n/a
9	chr6:30431577-30431627	BE2_C	brain:	n/a
10	chr6:30434552-30434602	HRE	kidney:	n/a
11	chr6:30434291-30434341	AG04449	skin:	fetal
12	chr6:30434208-30434258	BJ	skin:	n/a
13	chr6:30430828-30430878	HCM	heart:	n/a
14	chr6:30431782-30431832	GM06990	blood:	n/a
15	chr6:30434311-30434361	HCF	heart:	n/a
16	chr6:30431592-30431642	AG09309	skin:	n/a
17	chr6:30431592-30431642	HCF	heart:	n/a
18	chr6:30431592-30431642	ovcar-3	ovarian:	n/a
19	chr6:30434215-30434265	CMK	blood:	n/a
20	chr6:30434072-30434122	HMEC	breast:	n/a
21	chr6:30433423-30433473	Caco-2	colon:	n/a
22	chr6:30431590-30431640	BE2_C	brain:	n/a
23	chr6:30434523-30434573	K562	blood:	n/a
24	chr6:30434324-30434374	HNPCEpiC	eye:	n/a
25	chr6:30431592-30431642	A549	lung:	n/a
26	chr6:30434525-30434575	SK-N-MC	brain:	n/a
27	chr6:30434421-30434471	NB4	blood:	n/a
28	chr6:30431704-30431754	HUVEC	blood vessel:	n/a
29	chr6:30433888-30433938	T-47D	breast:	n/a
30	chr6:30431724-30431774	NHDF-neo	bronchial:	n/a
31	chr6:30431704-30431754	HRCEpiC	kidney:	n/a
32	chr6:30431724-30431774	HAEpiC	amniotic membrane:	n/a
33	chr6:30434215-30434265	SK-N-SH	brain:	n/a
34	chr6:30434236-30434286	AG04450	lung:	fetal
35	chr6:30433943-30433993	MCF-7	breast:	n/a
36	chr6:30434072-30434122	HAEpiC	amniotic membrane:	n/a
37	chr6:30434129-30434179	A549	lung:	n/a
38	chr6:30434412-30434462	AG09319	gingival:	n/a
39	chr6:30434523-30434573	ovcar-3	ovarian:	n/a
40	chr6:30431770-30431820	HMEC	breast:	n/a
41	chr6:30430828-30430878	PFSK-1	brain:	n/a
42	chr6:30431592-30431642	HEEpiC	esophagus:	n/a
43	chr6:30431596-30431646	SK-N-SH	brain:	n/a
44	chr6:30431563-30431613	HRCEpiC	kidney:	n/a
45	chr6:30434525-30434575	NHBE	bronchial:	n/a
46	chr6:30434109-30434159	MCF-7	breast:	n/a
47	chr6:30434109-30434159	HEK293	kidney:	embryo
48	chr6:30437493-30437543	HMEC	breast:	n/a
49	chr6:30433943-30433993	AG04449	skin:	fetal
50	chr6:30434129-30434179	AG09319	gingival:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:30446515..30448275-chr6:30457111..30458820,2	K562	blood:
2	chr6:30447949..30451648-chr6:30569801..30572499,4	MCF-7	breast:
3	chr6:30447631..30450065-chr6:30691817..30695001,3	K562	blood:
4	chr6:30431634..30434565-chr6:30582972..30585070,2	K562	blood:
5	chr6:30430770..30433095-chr6:30579406..30582231,2	K562	blood:
6	chr6:30418502..30422305-chr6:30429667..30432220,3	MCF-7	breast:
7	chr6:30447797..30449612-chr6:30512660..30515323,2	MCF-7	breast:
8	chr6:30446384..30451689-chr6:30578094..30585004,12	MCF-7	breast:
9	chr6:30433130..30435301-chr6:30582917..30586018,4	MCF-7	breast:
10	chr6:30446309..30448997-chr6:30451629..30454419,2	MCF-7	breast:
11	chr6:30431267..30434167-chr6:30612886..30615610,2	MCF-7	breast:
12	chr6:30431634..30435485-chr6:30582972..30586314,3	K562	blood:
13	chr6:30428958..30430493-chr6:30439620..30441525,2	MCF-7	breast:
14	chr6:30447476..30449412-chr6:30509865..30511998,2	K562	blood:

Variant related genes	Relation type
SUCLA2P1	TF binding region
TMPOP1	TF binding region
SUCLA2P1	CpG island
TMPOP1	CpG island
ENSG00000204564	chromatin interactions
ENSG00000204592	chromatin interactions
ENSG00000204568	chromatin interactions
ENSG00000236603	chromatin interactions
ENSG00000222894	chromatin interactions
ENSG00000204569	chromatin interactions

Extended variants
information (count: 221 )
Associated
traits (count: 121 )

Variant overlapped rSNPs/rCNVs (count:221 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs35792611	chr6:30430875-30430876	Bivalent Enhancer Enhancers	CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs190102701	chr6:30430924-30430925	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs554612218	chr6:30430928-30430929	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs141153834	chr6:30430993-30430994	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs115266049	chr6:30431011-30431012	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs182322570	chr6:30431049-30431050	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs114017174	chr6:30431083-30431084	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs114765125	chr6:30431151-30431152	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs377175398	chr6:30431167-30431168	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs564993108	chr6:30431174-30431175	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs115332725	chr6:30431201-30431202	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs550528108	chr6:30431202-30431203	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs114278990	chr6:30431325-30431326	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs529919591	chr6:30431337-30431338	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs200760395	chr6:30431356-30431357	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs116505144	chr6:30431407-30431408	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs59168158	chr6:30431579-30431580	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs538874981	chr6:30431581-30431582	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs373266083	chr6:30431585-30431586	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs568930027	chr6:30431591-30431592	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs150736782	chr6:30431596-30431597	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs554577409	chr6:30431598-30431599	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs372008799	chr6:30431630-30431631	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs562459233	chr6:30431656-30431657	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs116287286	chr6:30431663-30431664	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
26	rs59865400	chr6:30431693-30431694	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs573463394	chr6:30431704-30431705	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
28	rs545544446	chr6:30431717-30431718	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
29	rs565152866	chr6:30431722-30431723	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
30	rs575307599	chr6:30431789-30431790	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
31	rs113589582	chr6:30431820-30431821	Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
32	rs550471991	chr6:30431874-30431875	Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
33	rs146497346	chr6:30431929-30431930	Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
34	rs139968057	chr6:30431963-30431964	Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
35	rs530150871	chr6:30432020-30432021	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
36	rs112668398	chr6:30432039-30432040	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
37	rs546577180	chr6:30432047-30432048	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
38	rs186591730	chr6:30432139-30432140	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
39	rs532312721	chr6:30432152-30432153	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
40	rs62407197	chr6:30432153-30432154	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs373163048	chr6:30432165-30432166	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs376413860	chr6:30432179-30432180	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
43	rs371153514	chr6:30432180-30432181	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
44	rs372457077	chr6:30432201-30432202	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs368524339	chr6:30432256-30432257	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
46	rs28595412	chr6:30432275-30432276	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
47	rs2245507	chr6:30432308-30432309	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
48	rs569529963	chr6:30432380-30432381	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs34124993	chr6:30432402-30432403	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs116600325	chr6:30432410-30432411	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:121)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Melanoma	17363583	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Breast cancer	21364760	CNVD
Lung cancer	21569311	CNVD
Systemic lupus erythematosus	19279649	CNVD
Retinoblastoma	16790693	CNVD
Acute myocardial infarction	18032375	CNVD
Renal cell carcinoma	19150565	CNVD
Systemic lupus erythematosus	19591781	CNVD
Attention deficit hyperactivity disorder	19287146	CNVD
Autism	19287146	CNVD
Erythema nodosum in leprosy	19287146	CNVD
Henoch-schoenlein purpura	19287146	CNVD
Liver cirrhosis	19287146	CNVD
Systemic lupus erythematosus	19287146	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Systemic lupus erythematosus	19287147	CNVD
Osteosarcoma	16790693	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:487 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:30429800-30431200	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
2	chr6:30429800-30431400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
3	chr6:30429800-30434200	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
4	chr6:30430200-30431200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
5	chr6:30430400-30431000	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
6	chr6:30430400-30431000	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
7	chr6:30430400-30431200	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
8	chr6:30430400-30431200	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
9	chr6:30430400-30431200	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
10	chr6:30430600-30431000	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
11	chr6:30430600-30431000	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
12	chr6:30430600-30431200	Bivalent Enhancer	Primary T cells from cord blood	blood
13	chr6:30430600-30431400	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
14	chr6:30430600-30431600	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
15	chr6:30430800-30431200	Bivalent Enhancer	Primary B cells from cord blood	blood
16	chr6:30430800-30431200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
17	chr6:30430800-30431400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
18	chr6:30430800-30431400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
19	chr6:30430800-30431600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
20	chr6:30430800-30432400	Bivalent Enhancer	Fetal Thymus	thymus
21	chr6:30431000-30431200	Bivalent Enhancer	Duodenum Mucosa	Duodenum
22	chr6:30431000-30431200	Bivalent Enhancer	Lung	lung
23	chr6:30431000-30431200	Bivalent Enhancer	Small Intestine	intestine
24	chr6:30431000-30431400	Flanking Bivalent TSS/Enh	Primary T helper memory cells from peripheral blood 2	blood
25	chr6:30431000-30431400	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
26	chr6:30431000-30431400	Flanking Bivalent TSS/Enh	Primary T killer memory cells from peripheral blood	blood
27	chr6:30431000-30431400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
28	chr6:30431000-30431400	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
29	chr6:30431000-30431400	Bivalent Enhancer	Colonic Mucosa	Colon
30	chr6:30431000-30431400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
31	chr6:30431000-30431400	Enhancers	Spleen	Spleen
32	chr6:30431000-30431400	Bivalent Enhancer	HMEC	breast
33	chr6:30431000-30431600	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
34	chr6:30431000-30431600	Bivalent Enhancer	Right Ventricle	heart
35	chr6:30431000-30432000	Flanking Bivalent TSS/Enh	Primary T regulatory cells fromperipheralblood	blood
36	chr6:30431000-30432000	Bivalent Enhancer	Dnd41	blood
37	chr6:30431000-30432000	Bivalent Enhancer	GM12878-XiMat	blood
38	chr6:30431000-30432000	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
39	chr6:30431000-30432200	Enhancers	Gastric	stomach
40	chr6:30431000-30432400	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
41	chr6:30431000-30432400	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
42	chr6:30431000-30432400	Bivalent Enhancer	Colon Smooth Muscle	Colon
43	chr6:30431000-30432400	Enhancers	Pancreas	Pancrea
44	chr6:30431000-30432400	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
45	chr6:30431000-30432600	Bivalent Enhancer	Primary hematopoietic stem cells	blood
46	chr6:30431000-30432600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr6:30431000-30432600	Bivalent Enhancer	Adipose Nuclei	Adipose
48	chr6:30431200-30431400	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr6:30431200-30431400	Bivalent Enhancer	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
50	chr6:30431200-30431400	Flanking Bivalent TSS/Enh	Primary B cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links